시장 소개
종양 용해성 바이러스는 암세포에 유리하게 감염되어 죽이는 독특한 바이러스입니다. 이들은 암 면역요법의 일부로 배치되며 암 세포를 선택적으로 표적으로 삼고 종양 용해를 수행함으로써 작용합니다. 종양용해성 바이러스는 암세포를 직접 죽이고 환자 자신의 항종양 면역 반응을 자극하는 것으로 알려져 있습니다. 최초의 종양 용해성 바이러스 면역요법은 피부 흑색종 치료를 위해 2004년 라트비아에서 승인되었습니다. 인간 활동으로 인해 발생하는 불가피한 환경 변화는 다양한 요인을 발생시켜 비흑색종 피부암을 비롯한 수많은 피부 악성종양의 발병률을 증가시키고 있습니다. 피부 흑색종을 비롯한 다양한 암 치료를 위한 기존의 방사선 및 화학 요법은 치료 지수가 제한되어 있고 치료 관련 부작용이 많습니다. 미국 FDA가 승인한 최초의 종양 용해성 포진 바이러스(변형 단순 포진 바이러스)는 2015년 수술이 불가능한 진행성 흑색종 치료용으로 승인된 약물 talimogene laherparepvec(OncoVex, T-VEC)입니다.시장 역학
암 발생률 증가와 고급 치료 옵션 채택 증가로 인해 종양 용해 바이러스 시장의 수요가 증가할 것입니다. 그러나 치료 관련 표적 외 효과, 부작용, 약물 내성으로 인해 예측 기간 동안 시장 성장이 제한될 수 있습니다. 또한 연구 개발에 대한 막대한 투자와 개발도상국의 노인 인구 증가, 라이프스타일 변화로 인해 예측 기간 동안 시장 성장이 가속화될 것입니다.시장 범위
"2028년까지의 글로벌 종양 용해 바이러스 시장 분석"은 글로벌 시장 동향 분석에 특별히 초점을 맞춘 전문적이고 심층적인 연구입니다. 이 보고서는 제품 유형, 응용 프로그램, 최종 사용자 및 지역별로 상세한 시장 세분화를 통해 종양 용해 바이러스 시장에 대한 개요를 제공하는 것을 목표로 합니다. 글로벌 종양 용해성 바이러스 시장은 예측 기간 동안 높은 성장을 보일 것으로 예상됩니다. 이 보고서는 주요 종양 용해 바이러스 시장 플레이어의 시장 상태에 대한 주요 통계를 제공하고 시장의 주요 추세와 기회를 제공합니다.시장 세분화
글로벌 종양 용해 바이러스 시장은 제품 유형, 애플리케이션 및 최종 사용자를 기준으로 분류됩니다. 제품 유형에 따라 전 세계 종양 용해 바이러스 시장은 HSV 기반 종양 용해 바이러스, 아데노바이러스 기반 종양 용해 바이러스, 우두 바이러스 기반 종양 용해 바이러스, 수포성 구내염 바이러스 기반 종양 용해 바이러스 및 뉴캐슬병 바이러스 기반 종양 용해 바이러스로 분류됩니다. 응용 분야에 따라 전 세계 종양 용해성 바이러스 시장은 유방암, 폐암, 전립선 암, 흑색종, 뇌종양, 혈액암 등으로 분류됩니다. 최종 사용자를 기준으로 종양 용해 바이러스 시장은 병원, 전문 진료소 및 암 연구 기관으로 분류됩니다.지역적 프레임워크
이 보고서는 질적 및 양적 정보를 모두 포함하여 업계에 대한 자세한 개요를 제공합니다. 다양한 부문을 기반으로 글로벌 종양 용해 바이러스 시장에 대한 개요 및 예측을 제공합니다. 또한 5개 주요 지역에 대해 2019년부터 2028년까지 시장 규모와 예측 추정치를 제공합니다. 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA), 중남미. 각 지역별 종양 용해 바이러스 시장은 나중에 각 국가 및 부문별로 세분화됩니다. 이 보고서는 전 세계 18개국에 대한 분석 및 예측과 함께 해당 지역에 만연한 현재 추세 및 기회를 다루고 있습니다. 이 보고서는 수요 및 공급 측면에서 종양 용해성 바이러스 시장에 영향을 미치는 요인을 분석하고 예측 기간 동안 시장에 영향을 미치는 시장 역학, 즉 동인, 제한 사항, 기회 및 미래 추세를 추가로 평가합니다. 이 보고서는 또한 5개 지역 모두에 대한 철저한 PEST 분석을 제공합니다. 이 지역의 종양 용해 바이러스 시장에 영향을 미치는 정치적, 경제적, 사회적 및 기술적 요인을 평가한 후 북미, 유럽, APAC, MEA 및 중남미.시장 참가자
보고서는 유기 및 무기 성장 전략으로서 종양 용해 바이러스 시장의 주요 발전을 다루고 있습니다. 다양한 기업들이 제품 출시, 제품 승인, 특허, 이벤트 등 유기적인 성장 전략에 주력하고 있습니다. 시장에서 목격된 무기 성장 전략 활동은 인수, 파트너십 및 협업이었습니다. 이러한 활동은 시장 참가자의 비즈니스 및 고객 기반 확장을 위한 길을 열었습니다. 종양 용해성 바이러스 시장의 시장 참가자들은 세계 시장에서 종양 용해성 바이러스에 대한 수요가 증가함에 따라 향후 수익성 있는 성장 기회를 얻을 것으로 예상됩니다. 아래에는 종양 용해 바이러스 시장에 참여하는 몇몇 회사의 목록이 나와 있습니다. 이 보고서에는 SWOT 분석 및 시장 전략과 함께 주요 종양 용해 바이러스 시장 회사의 프로필도 포함되어 있습니다. 또한 이 보고서는 회사 프로필, 제공된 구성 요소 및 서비스, 지난 3년간의 재무 정보, 지난 5년간의 주요 개발과 같은 정보를 제공하는 업계 선두 기업에 중점을 둡니다.- • 암젠(Amgen Inc) • Oncolytics Biotech, Inc. • 머크 앤 컴퍼니(Merck & Co., Inc.) • 이식유전자 • 온콜리스 바이오파마(Oncolys BioPharma Inc.) • Targovax ASA • 비리아드 주식회사 • Genelux Corporation • 소렌토 테라퓨틱스(Sorrento Therapeutics, Inc.) • Lokon Pharma AB
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. Amgen Inc
2. Oncolytics Biotech, Inc.
3. Merck & Co., Inc.
4. Transgene
5. Oncolys BioPharma Inc.
6. Targovax ASA
7. Vyriad Inc.
8. Genelux Corporation
9. Sorrento Therapeutics, Inc.
10. Lokon Pharma AB
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Apr 2024
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2024
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2024
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Apr 2024
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Apr 2024
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Apr 2024
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)